BSECompany UpdateResults2d ago
Velox Shipping and Logistics Ltd
Newspaper publication of unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026
Velox Shipping and Logistics Ltd has published its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in newspapers as per SEBI regulations.
NSECopy of Newspaper PublicationResults2d ago
Airo Lam limited
Copy of Newspaper Publication
Airo Lam Limited has informed the Exchange about the publication of its standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026, as published in the SEBI (LODR) Regulations, 2018.
BSECompany UpdateResults2d ago
Black Box Ltd
Pursuant to Regulation 30 of SEBI (LODR) Reg., 2015, please find attached herewith intimation of earnings call for unaudited financial results for Q2FY27.
Black Box Ltd has announced an earnings call for Q2FY27 financial results, scheduled for November 14, 2026. The call will be led by the CEO, Global CFO, and Head of Investor Relations. Participants can pre-register for the call through a provided link.
BSECompany UpdateResults2d ago
Black Box Ltd
Pursuant to Regulation 30 of SEBI (LODR) Reg., 2015, please find attached herewith intimation of earnings call for unaudited financial results for Q2FY27.
Black Box Ltd has announced an earnings call for Q2FY27 financial results, scheduled for November 14, 2026. The call will be led by the company's CEO, CFO, and Head of Investor Relations. Participants can pre-register for the call through a provided link.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults2d ago
Black Box Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Black Box Limited has informed the Exchange about the schedule of its earnings call for Q2 & H1 FY27, to be held on November 14, 2026, at 10:00 A.M. IST. The call will be attended by the company's officials, including the CEO, Global CFO, and Head of Investor Relations.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Chief Investment Officer, as per the company update.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed the BSE about the appointment of a Chief Investment Officer. This is a routine update to the company's management structure.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer, as part of its organizational structure changes.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer, as part of its organizational structure changes.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
GLAND PHARMA LIMITED has informed BSE about the appointment of a Chief Investment Officer.
BSECompany UpdateMgmt Change2d ago
GLAND PHARMA LIMITED
GLAND PHARMA LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%">
<tbody>
<tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr>
<tr><td ....
Gland Pharma Limited has informed BSE about the appointment of a Chief Investment Officer, a change in key managerial personnel.